ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2022, Vol. 31 ›› Issue (2): 180-184.DOI: 10.3969/j.issn.1006-298X.2022.02.017

• • 上一篇    下一篇

慢性肾脏病相关性瘙痒

  

  • 出版日期:2022-04-28 发布日期:2022-04-21

Chronic kidney diseaseassociated pruritus

  • Online:2022-04-28 Published:2022-04-21

摘要: 慢性肾脏病相关性瘙痒症(CKDaP)是慢性肾脏病患者常见且令人困扰的并发症,其患病率为20%~40%,严重影响患者生活质量,增加患者死亡风险,临床缺少专业的CKDaP测量和评估量表,易被忽视和低估。目前CKDaP发病机制主要有毒素沉积、免疫系统失调、周围神经病变和阿片类物质紊乱等假说,而新型阿片类药物临床试验证实了其有效性和安全性,是CKDaP治疗的新希望。


关键词: 慢性肾脏病相关性瘙痒, 发病机制, 量表, 治疗进展

Abstract: Chronic kidney diseaseassociated pruritus (CKDaP) is a common,troubling problem for patients with CKD.Despite a prevalence rate of approximately 20%~40% in CKD, and a clear association with poorer psychosocial and medical outcomes, this condition is often ignored or underreported by patients or health care providers. This is likely due to uncertainty regarding its pathogenesis and treatment. CKDaP is attributed to toxin buildup, peripheral neuropathy, immune system dysregulation, or opioid dysregulation.Recently, targeting opioid dysregulation have yielded promising results. These trials have spurred new hope for understanding and treating this condition.


Key words: chronic kidney disease-associated pruritus, pathogenesis, scale, treatment progress